INTERNATIONAL PATENT: AMGEN RESEARCH (MUNICH) GMBH, AMGEN INC. FILES APPLICATION FOR "METHODS FOR TREATING PROSTATE CANCER WITH BISPECIFIC ANTIBODIES BINDING STEAP1XCD3"

GENEVA, March 4 -- AMGEN RESEARCH (MUNICH) GMBH (Staffelseestrasse 281477 Munich), AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2024/042988) for "METHODS FOR TREATING PROSTATE CANCER WITH BISPECIFIC ANTIBODIES BINDING STEAP1XCD3" on Aug 20, 2024. With publication no. WO/2025/042865, the details related to the patent application was published on Feb 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STIEGLMAIER, Julia (c/o Amgen Research (Munich) GmbHStaffelseestrasse 281477 Munich), KISCHEL, Roman (c/o Amgen Research (Munich) GmbHStaffels...